Coherus Oncology, Inc. (CHRS)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for Coherus Oncology, Inc.. Most notable: 2026-08-17: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | Satvat Ali J. | director | A | 30,000 | 0 | $0 |
| 2026-06-05 | Karachun Rita A | director | A | 30,000 | 0 | $0 |
| 2026-06-05 | Newcomer Lee Nisley | director | A | 30,000 | 0 | $0 |
| 2026-06-05 | Ryan Michael Lee | director | A | 30,000 | 0 | $0 |
| 2026-06-05 | O'Donnell-Tormey Jill | director | A | 30,000 | 0 | $0 |
| 2026-06-05 | Wahlstrom Mats | director | A | 30,000 | 0 | $0 |
| 2026-06-05 | Newton Charles W. | director | A | 30,000 | 0 | $0 |
| 2026-01-23 | Lanfear Dennis M | director | A | 375,000 | 0 | $0 |
| 2026-01-22 | McMichael Bryan J | officer | A | 112,500 | 0 | $0 |
| 2026-01-20 | McMichael Bryan J | officer | F | 1,715 | 1.55 | $2,658 |
| 2026-01-20 | Lanfear Dennis M | director | F | 11,839 | 1.55 | $18,350 |
| 2025-05-23 | Wahlstrom Mats | director | S | 99,988 | 0.74 | $73,991 |
| 2025-01-20 | McMichael Bryan J | officer | F | 1,711 | 1.39 | $2,378 |
| 2025-01-20 | Reider Paul | officer | F | 4,858 | 1.39 | $6,753 |
| 2025-01-20 | Lanfear Dennis M | director | F | 11,810 | 1.39 | $16,416 |
| 2025-01-07 | McMichael Bryan J | officer | F | 1,711 | 1.57 | $2,686 |
| 2025-01-04 | Lanfear Dennis M | director | F | 11,810 | 1.66 | $19,605 |
| 2025-01-04 | Reider Paul | officer | F | 2,277 | 1.66 | $3,780 |
| 2024-12-13 | Reider Paul | officer | F | 2,073 | 1.61 | $3,338 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.